GLP-1 weight loss drugs effective even at low starter doses

The GLP-1 drugs semaglutide, sold as Ozempic and Wegovy by Novo Nordisk, and Eli Lilly's tirzepatide, sold under ‌the brand names Mounjaro and Zepbound, are prescribed initially at a low dose followed by gradual titration to higher doses, to help the body adjust ‌and minimize side effects